Steps toward safe cell therapy using induced pluripotent stem cells. - Wikidata - awgldk - TriplyDB

Steps toward safe cell therapy using induced pluripotent stem cells.

Steps toward safe cell therapy using induced pluripotent stem cells.

http://www.wikidata.org/entity/Q34325607

about

Mechanoresponsive musculoskeletal tissue differentiation of adipose-derived stem cells Applications of Mesenchymal Stem Cells and Neural Crest Cells in Craniofacial Skeletal Research The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges Prospects and Challenges of Induced Pluripotent Stem Cells in Equine Health Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application Long-term maintenance of human induced pluripotent stem cells by automated cell culture system Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling Developing miRNA therapeutics for cardiac repair in ischemic heart disease A review on the use of cell therapy in the treatment of tendon disease and injuries Banking on iPSC--is it doable and is it worthwhile Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation The Tissue-Engineered Vascular Graft-Past, Present, and Future.Cell therapy for spinal cord injury informed by electromagnetic waves.Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke.Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.Efficacy and Safety of Immuno-Magnetically Sorted Smooth Muscle Progenitor Cells Derived from Human-Induced Pluripotent Stem Cells for Restoring Urethral Sphincter Function Generation of bladder urothelium from human pluripotent stem cells under chemically defined serum- and feeder-free system.The stem cell secretome and its role in brain repair.Generation of thyroid follicular cells from pluripotent stem cells: potential for regenerative medicine.Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis.In-depth characterisation of Retinal Pigment Epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSC).Tumour resistance in induced pluripotent stem cells derived from naked mole-rats.Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice "Footprint-free" human induced pluripotent stem cell-derived astrocytes for in vivo cell-based therapy.In vivo conversion of astrocytes to neurons in the injured adult spinal cord Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes Regeneration of uterine horns in rats using collagen scaffolds loaded with human embryonic stem cell-derived endometrium-like cells.

P2860

Q26751173-C59E15C3-55D9-43FD-8E5B-5D990586D5E4 Q26752482-05D248DA-7919-4EC9-86C5-DAA5F158F979 Q26765876-0BBF5B02-7B0D-45AC-8CBF-65D3932290D3 Q26772879-D39500A9-8B14-4493-8823-9619F55A6CB5 Q26776053-6FD738ED-FAE4-4750-B669-D61109920126 Q26778010-896C04FA-09A6-455B-9B6C-574FABCECCE2 Q26784399-72347717-A83E-400A-9C64-622330797A19 Q26849530-1BF2493D-626E-4ECF-8489-1C98DDC45B1F Q26853054-056FC5A3-4A26-4A8D-B6F8-63FC0A158BEA Q27306156-8A3086F8-B72E-41C3-9EB1-C30366B8AB8A Q27307068-1E1B0A06-E9F0-4DF7-8771-F7F6FF24E329 Q28066087-78317A91-44A7-4124-AF55-6CF7ABF34F0A Q28067160-7DBB7B3F-F4B7-4C5F-B2AF-1593A19DF2AA Q28076273-870F5159-DDBF-4594-8D72-2E94F0C6A6BA Q28077986-5E901685-8FB7-4637-8D87-B310857A2114 Q28251262-A2D6541A-7DA2-4576-A768-6529A8A2B2E3 Q28254023-86372E43-4423-4B07-9CDF-11F6AD0008AB Q28305306-140A4958-125D-4A70-9E58-6EBCB367DCC3 Q28543575-08469828-9E98-42E4-9AAA-F3C62C382460 Q30385854-B895FD0A-20D4-45E4-9576-F375B2470238 Q33363830-1888006C-CDD4-42B9-83DA-81B9B72C18EF Q33694696-19B28D0D-7207-4600-8525-44A60C5E3055 Q33699342-2CE5D73A-A584-4CF1-A59E-A02C549D6924 Q33722606-474D9BAD-5692-48BE-A3D7-178DC838F594 Q33755507-95130C3A-2ED8-4DF6-BC13-B49BD2788AA5 Q33771698-0A86FFC2-3883-4CDE-94AA-583BE11CFDB1 Q33775547-A4840A42-0BBA-41A6-8692-880588A782C4 Q33804981-D651C47B-55FF-4E42-8CB1-E3AD5CB0AC84 Q33826992-74F0C954-9A40-457B-99F7-E1AFD9D2125C Q33992629-7230EE91-9B6A-4D2D-B168-C52882FEB637 Q34046796-634D2584-0C7D-441E-B5EE-7227B2A61C30 Q34075012-028FC5DE-BE7C-45D1-AAC2-F5058A875A8F Q34246088-1D265C90-70EE-4EF3-95A1-96FB3397029E Q34360907-A2AE3B1E-8629-40E0-A0FA-0F8C8984F183 Q34406755-B6296694-2F96-4BC5-95C3-9108FEA6F721 Q34420563-7DD7F84D-D871-44B3-AA45-F238B81E1B11 Q34462874-661D8EB0-42CD-4B24-ABBD-A4A4D19BBF30 Q34541218-8466AC8A-2D56-4F6B-B690-53AB0F0298B7 Q34756386-83D3C69A-3C7D-41DB-9A0E-4F93AB0877FD Q34938368-5B5F3325-D1B5-47C8-8112-2CBC4D668264

P2860

Steps toward safe cell therapy using induced pluripotent stem cells.

http://www.wikidata.org/entity/Q34325607

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Steps toward safe cell therapy using induced pluripotent stem cells.

@ast

Steps toward safe cell therapy using induced pluripotent stem cells.

@en

Steps toward safe cell therapy using induced pluripotent stem cells.

@nl

type

label

Steps toward safe cell therapy using induced pluripotent stem cells.

@ast

Steps toward safe cell therapy using induced pluripotent stem cells.

@en

Steps toward safe cell therapy using induced pluripotent stem cells.

@nl

prefLabel

Steps toward safe cell therapy using induced pluripotent stem cells.

@ast

Steps toward safe cell therapy using induced pluripotent stem cells.

@en

Steps toward safe cell therapy using induced pluripotent stem cells.

@nl

P1433

Q34325607-1B9060BA-DBD8-4BEA-B65E-53B43070F923

P1476

Q34325607-D14D6DF4-FB25-4583-A4B7-726FBDC22107

P2093

Q34325607-14029419-7675-4126-AB2E-455E2F29E42B

Q34325607-1EDC9DD0-7CA9-409C-94E9-AA551EA13537

Q34325607-6AE49EA3-8CE5-4D39-9DEA-AFFEAEA6AF1D

Q34325607-93A93395-86D0-4A80-9D52-1AABFEE04185

Q34325607-B2C0555F-1FB9-48F1-8C69-47DE38F4B406

Q34325607-CC03D56D-BE6C-4423-BB7B-0A72F1DD3BF4

Q34325607-E4AB672D-03DF-415B-9AEC-1AF8D5D21B97

P304

Q34325607-2D564546-E039-46D3-B29F-3DF10BD54C2F

P31

Q34325607-4B1906EC-58C5-406D-BB5C-434B2093BD3D

P356

Q34325607-FEC44B7D-E549-49AA-BD41-2616C0457C55

P433

Q34325607-00C075D1-540F-4BB4-B2B8-7E46F579BF5E

P478

Q34325607-BC2CB08D-8BAB-4C38-B4E1-13A59FD40922

P50

Q34325607-4CC2243B-3F12-4F75-A356-7C23F726DDCA

Q34325607-55A24A69-D15B-44CF-A1CD-372D386251D2

P577

Q34325607-01BCC665-950A-432B-8DD5-EFBE52B25266

P698

Q34325607-FA8BE7AD-F5C6-4FA8-98D5-7174CFBA7C47

P356

CIRCRESAHA.111.256149

P1433

Circulation Research

P1476

Steps toward safe cell therapy using induced pluripotent stem cells.

@en

P2093

Eiji Ikeda

http://www.w3.org/2001/XMLSchema#string

Kenji Yoshida

http://www.w3.org/2001/XMLSchema#string

Kyoko Miura

http://www.w3.org/2001/XMLSchema#string

Masaya Nakamura

http://www.w3.org/2001/XMLSchema#string

Osahiko Tsuji

http://www.w3.org/2001/XMLSchema#string

Satoshi Nori

http://www.w3.org/2001/XMLSchema#string

Yohei Okada

http://www.w3.org/2001/XMLSchema#string

P304

523-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.111.256149

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Shinya Yamanaka

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23371901

http://www.w3.org/2001/XMLSchema#string